# Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-analysis-of-semaglutide-2-4-mg-for-the-treatment-of-adult/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nina Kim,Jessie Wang,Chakkarin Burudpakdee,Yan Song,Abhilasha Ramasamy,Yanwen Xie,Rochelle Sun,Neela Kumar,Eric Q. Wu,Sean D. Sullivan |
| Citations | 79 |
| DOI | 10.18553/jmcp.2022.28.7.740 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pmc.ncbi.nlm.nih.gov/articles/PMC10372962/pdf/jmcp.2022.28.7.740.pdf |
| OpenAlex ID | https://openalex.org/W4283455216 |
| PMID | 35737858 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Yan Song](https://scholariq.org/researchers/yan-song/)

## Paper journal

- [Journal of Managed Care & Specialty Pharmacy](https://scholariq.org/journals/journal-of-managed-care-and-specialty-pharmacy/)

## Paper primary topic

- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)

## Paper topics

- [Pharmacology and Obesity Treatment](https://scholariq.org/topics/pharmacology-and-obesity-treatment/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.